BioCentury
ARTICLE | Clinical News

AFN-1252 regulatory update

November 18, 2013 8:00 AM UTC

Affinium said FDA granted Qualified Infectious Disease Product (QIDP) designation for AFN-1252 to treat acute bacterial skin and skin structure infections (ABSSSI). The small molecule inhibitor of the...